You are here: Industry Insights > COVID-19

News List

Novateur Ventures explores new strategy to reduce hyperinflammatory response caused by COVID-19 expresspharma
August 10, 2020
Its study analyses lipid mediators, known as leukotrienes, as the cause for hyperinflammatory response manifested in severe COVID-19 cases.
Aurobindo Pharma joins COVID-19 vaccine hunt expresspharma
August 10, 2020
The company’s vaccine candidate has been shortlisted for BIRAC funding, will launch final product by the end of 2022.
Pfizer signs agreement with Gilead Sciences to manufacture remdesivir expresspharma
August 10, 2020
Pfizer will provide contract manufacturing services through its McPherson, Kansas plant.
RLF-100 shown to deliver rapid recovery from respiratory failure in Covid-19 patients pharmaceutical-business-review
August 07, 2020
NeuroRx and Relief Therapeutics said that RLF-100 (aviptadil) delivered quick recovery from respiratory failure in the most critically ill patients suffering from Covid-19 in a phase 2/3 clinical trial.
Second COVID-19 peak in the UK can be avoided with testing and tracing, study finds pharmatimes
August 07, 2020
Research co-led by UCL and the London School of Hygiene & Tropical Medicine has found that a second COVID-19 wave can be prevented if testing and tracing is scale-up in the UK.
Researchers says hydroxychloroquine could still prevent COVID-19 pharmatimes
August 07, 2020
Leading scientific researchers from the University of Oxford have said that the antiviral medication hydroxychloroquine is being ‘discarded prematurely’ and could still have benefit against COVID-19.
Beroni Successfully Constructs Purified Nanobodies for COVID-19 Detection and Treatment americanpharmaceuticalreview
August 07, 2020
Beroni Group has provided an update on the development of the previously announced potential medical solution utilizing nanobody technology for both detection and treatment of COVID-19 in collaboration with Tianjin University in China.
BioAegis Therapeutics Initiates Trial of Its Inflammation Regulator for COVID-19 Treatment americanpharmaceuticalreview
August 07, 2020
BioAegis Therapeutics enrolled its first patient in its Phase 2 study of hospitalized patients with severe COVID-19 pneumonia.
Glenmark to launch FabiFlu (400 mg) for COVID-19 treatment expresspharma
August 07, 2020
With the new 400 mg version, patients need to consume nine tablets on Day 1, and thereafter two tablets twice a day from Day 2 till the end of the course.
Upskilling pharma workforce to be future-ready expresspharma
August 07, 2020
Sanjeev Goel, Business Head, Manipal ProLearn highlights that the pharma sector needs an agile workforce to leverage opportunities and overcome challenges in a post-COVID world and emphasises that pharma organisations should assess and ...